- Investing Ideas
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
91
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
91 companies
Protagonist Therapeutics
Market Cap: US$6.4b
Operates as a discovery and development company in the United States.
PTGX
US$99.19
7D
-2.9%
1Y
117.2%
Annexon
Market Cap: US$870.0m
A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
ANNX
US$5.31
7D
1.9%
1Y
151.7%
Celcuity
Market Cap: US$6.7b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$138.23
7D
0.4%
1Y
1,224.0%
Formycon
Market Cap: €354.3m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€20.05
7D
6.2%
1Y
-9.9%
Prothena
Market Cap: US$514.6m
A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation.
PRTA
US$9.83
7D
0.7%
1Y
49.4%
Immix Biopharma
Market Cap: US$612.8m
A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.
IMMX
US$8.78
7D
-11.7%
1Y
341.2%
Plus Therapeutics
Market Cap: US$45.2m
A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
PSTV
US$6.59
7D
25.5%
1Y
-11.8%
Guard Therapeutics International
Market Cap: SEK 27.0m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.34
7D
-7.6%
1Y
-91.7%
Medivir
Market Cap: SEK 1.0b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.89
7D
-5.2%
1Y
6.2%
Caris Life Sciences
Market Cap: US$4.4b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$15.55
7D
6.9%
1Y
n/a
Heron Therapeutics
Market Cap: US$162.6m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
HRTX
US$0.86
7D
1.0%
1Y
-53.6%
Immunocore Holdings
Market Cap: US$1.5b
Engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally.
IMCR
US$28.83
7D
2.8%
1Y
-7.5%
Vitrolife
Market Cap: SEK 14.5b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 106.80
7D
2.7%
1Y
-27.8%
Aroa Biosurgery
Market Cap: AU$216.2m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.63
7D
0.8%
1Y
38.9%
SynAct Pharma
Market Cap: SEK 784.0m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 14.00
7D
-3.3%
1Y
-22.7%
BioInvent International
Market Cap: SEK 1.8b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 27.50
7D
19.6%
1Y
-11.7%
Nanjing Vazyme Biotech
Market Cap: CN¥8.0b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥20.13
7D
3.3%
1Y
-7.9%
Zymeworks
Market Cap: US$1.9b
A biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.
ZYME
US$25.61
7D
7.0%
1Y
121.9%
Natera
Market Cap: US$29.1b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$203.19
7D
9.0%
1Y
32.5%